Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,150.20
-5.00 (-0.43%)
Jun 13, 2025, 3:30 PM IST

Aurobindo Pharma Statistics

Total Valuation

NSE:AUROPHARMA has a market cap or net worth of INR 668.04 billion. The enterprise value is 668.25 billion.

Market Cap 668.04B
Enterprise Value 668.25B

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date May 28, 2025
Ex-Dividend Date n/a

Share Statistics

NSE:AUROPHARMA has 580.80 million shares outstanding. The number of shares has decreased by -0.53% in one year.

Current Share Class 580.80M
Shares Outstanding 580.80M
Shares Change (YoY) -0.53%
Shares Change (QoQ) -0.05%
Owned by Insiders (%) 15.31%
Owned by Institutions (%) 33.52%
Float 272.90M

Valuation Ratios

The trailing PE ratio is 19.23 and the forward PE ratio is 16.51. NSE:AUROPHARMA's PEG ratio is 1.58.

PE Ratio 19.23
Forward PE 16.51
PS Ratio 2.11
PB Ratio 2.05
P/TBV Ratio 2.35
P/FCF Ratio 34.14
P/OCF Ratio 17.02
PEG Ratio 1.58
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 34.15.

EV / Earnings 19.17
EV / Sales 2.11
EV / EBITDA 10.17
EV / EBIT 13.57
EV / FCF 34.15

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.25.

Current Ratio 1.85
Quick Ratio 0.95
Debt / Equity 0.25
Debt / EBITDA 1.25
Debt / FCF 4.22
Interest Coverage 10.84

Financial Efficiency

Return on equity (ROE) is 11.15% and return on invested capital (ROIC) is 8.00%.

Return on Equity (ROE) 11.15%
Return on Assets (ROA) 6.53%
Return on Invested Capital (ROIC) 8.00%
Return on Capital Employed (ROCE) 14.12%
Revenue Per Employee 12.19M
Profits Per Employee 1.34M
Employee Count 26,015
Asset Turnover 0.67
Inventory Turnover 1.28

Taxes

In the past 12 months, NSE:AUROPHARMA has paid 15.83 billion in taxes.

Income Tax 15.83B
Effective Tax Rate 31.24%

Stock Price Statistics

The stock price has decreased by -7.91% in the last 52 weeks. The beta is 0.22, so NSE:AUROPHARMA's price volatility has been lower than the market average.

Beta (5Y) 0.22
52-Week Price Change -7.91%
50-Day Moving Average 1,175.23
200-Day Moving Average 1,268.74
Relative Strength Index (RSI) 44.60
Average Volume (20 Days) 1,110,366

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:AUROPHARMA had revenue of INR 317.24 billion and earned 34.86 billion in profits. Earnings per share was 59.81.

Revenue 317.24B
Gross Profit 186.97B
Operating Income 49.56B
Pretax Income 50.66B
Net Income 34.86B
EBITDA 66.05B
EBIT 49.56B
Earnings Per Share (EPS) 59.81
Full Income Statement

Balance Sheet

The company has 82.36 billion in cash and 82.63 billion in debt, giving a net cash position of -273.70 million or -0.47 per share.

Cash & Cash Equivalents 82.36B
Total Debt 82.63B
Net Cash -273.70M
Net Cash Per Share -0.47
Equity (Book Value) 326.47B
Book Value Per Share 562.37
Working Capital 124.80B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 39.25 billion and capital expenditures -19.68 billion, giving a free cash flow of 19.57 billion.

Operating Cash Flow 39.25B
Capital Expenditures -19.68B
Free Cash Flow 19.57B
FCF Per Share 33.69
Full Cash Flow Statement

Margins

Gross margin is 58.94%, with operating and profit margins of 15.62% and 10.99%.

Gross Margin 58.94%
Operating Margin 15.62%
Pretax Margin 15.97%
Profit Margin 10.99%
EBITDA Margin 20.82%
EBIT Margin 15.62%
FCF Margin 6.17%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.26%.

Dividend Per Share 3.00
Dividend Yield 0.26%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 0.03%
Buyback Yield 0.53%
Shareholder Yield 0.79%
Earnings Yield 5.22%
FCF Yield 2.93%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.

Last Split Date Jul 20, 2015
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score 6